TherapeuticsMD
TXMD
#10149
Rank
NZ$34.82 M
Marketcap
NZ$3.01
Share price
4.19%
Change (1 day)
51.97%
Change (1 year)

TherapeuticsMD (TXMD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$19.41 Million

According to TherapeuticsMD's latest financial reports the company's total liabilities are NZ$19.41 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

TherapeuticsMD - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$20.3 M-8.42%
2023-12-31NZ$22.17 M-74.55%
2022-12-31NZ$87.12 M-77.38%
2021-12-31NZ$0.38 B-9.06%
2020-12-31NZ$0.42 B11.09%
2019-12-31NZ$0.38 B123.44%
2018-12-31NZ$0.17 B809.74%
2017-12-31NZ$18.75 M-13.28%
2016-12-31NZ$21.62 M38.8%
2015-12-31NZ$15.58 M14.22%
2014-12-31NZ$13.64 M53.21%
2013-12-31NZ$8.9 M-0.45%
2012-12-31NZ$8.94 M121.6%
2011-12-31NZ$4.03 M1237.54%
2010-12-31NZ$0.3 M-81.12%
2009-12-31NZ$1.59 M2496.35%
2008-12-31NZ$0.06 M-39.41%
2007-12-31NZ$0.1 M-60.2%
2006-12-31NZ$0.25 M-64.62%
2005-12-31NZ$0.72 M1287.22%
2004-12-31NZ$0.05 M5.3%
2003-12-31NZ$0.04 M53.84%
2002-12-31NZ$0.03 M-42.13%
2001-12-31NZ$0.05 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Agile Therapeutics
AGRX
NZ$63.76 M 228.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
NZ$1.29 B 6,552.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$199.95 B 1,029,872.39%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$236.03 B 1,215,692.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
NZ$16.81 B 86,534.19%๐Ÿ‡ฌ๐Ÿ‡ง UK